AXSM

Axsome Therapeutics, Inc.

1 day chart

About AXSM

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is developing and delivering novel therapies for the central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of the major depressive disorder (MDD). Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. Its AXS-05 is an oral, investigational NMDA receptor antagonist with multimodal activity for the treatment of Alzheimer's disease agitation (AD agitation) and smoking cessation. Its AXS-07 is a multi-mechanistic, investigational medicine under development for the acute treatment of migraine.

Buy US stocks in Australia starting with AXSM. Open an account and start investing today!

Market Capitalisation

$3.60B

Price-earnings ratio

Dividend yield

0.00%

Volume

1.59M

High today

$76.25

Low today

$74.65

Open price

$76.06

52-week high

$91.29

52-week low

$38.87

AXSM FAQs

Can I buy AXSM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy AXSM shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Axsome Therapeutics, Inc.?

One share of Axsome Therapeutics, Inc. is valued at $75.68.

What is the ticker symbol for Axsome Therapeutics, Inc.?

The ticker symbol for Axsome Therapeutics, Inc. is AXSM.

How do I buy AXSM shares in Australia?

To buy AXSM stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in AXSM

What is the 52-week high for Axsome Therapeutics, Inc. stock?

The Axsome Therapeutics, Inc. 52-week high stock price is $91.29.

What is the 52-week low for Axsome Therapeutics, Inc. stock?

The Axsome Therapeutics, Inc. 52-week low stock price is $38.87.

What is the market capitalisation of Axsome Therapeutics, Inc. AXSM?

As of 16/09/2023 Axsome Therapeutics, Inc. has a market cap of $3.6B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.